Novamigra Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.52M

  • Investors
  • 4

Novamigra Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop novel oral therapies that transform migraine prevention and address unmet medical needs. The company offers a first-in-class oral prophylactic treatment with a novel mechanism of action targeting resistant migraine patients, enabling customers to achieve improved quality of life through safer, more effective and accessible migraine prevention services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Budapest
  • Hungary
Primary Industry
Biotechnology
Corporate Office
  • Budapest
  • Hungary

Novamigra Therapeutics Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novamigra Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 09-Jan-2026 $3.52M Completed Clinical Trials - Phase 1
2. Grant Completed Clinical Trials - Phase 1
1. Spin-Off 14-Jan-2025 Completed Clinical Trials - Phase 1
To view Novamigra Therapeutics’s complete valuation and funding history, request access »

Novamigra Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
PMK-Group Venture Capital Minority
Széchenyi Funds Venture Capital Minority
Vascular Venture Venture Capital Minority
National Research, Development and Innovation Office Government
To view Novamigra Therapeutics’s complete investors history, request access »

Novamigra Therapeutics FAQs

  • When was Novamigra Therapeutics founded?

    Novamigra Therapeutics was founded in 2025.

  • Where is Novamigra Therapeutics headquartered?

    Novamigra Therapeutics is headquartered in Budapest, Hungary.

  • What industry is Novamigra Therapeutics in?

    Novamigra Therapeutics’s primary industry is Biotechnology.

  • Is Novamigra Therapeutics a private or public company?

    Novamigra Therapeutics is a Private company.

  • What is Novamigra Therapeutics’s current revenue?

    The current revenue for Novamigra Therapeutics is .

  • How much funding has Novamigra Therapeutics raised over time?

    Novamigra Therapeutics has raised $3.52M.

  • Who are Novamigra Therapeutics’s investors?

    PMK-Group, Széchenyi Funds, Vascular Venture, and National Research, Development and Innovation Office have invested in Novamigra Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process